TransMedics Group (TMDX) Earnings Date & Reports

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

TMDX is expected to report earnings to fall 48.10% to 36 cents per share on July 31

TransMedics Group TMDX Stock Earnings Reports

Q2'25

Est.

$0.36

Q1'25

Beat

by $0.44

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.14

The last earnings report on May 08 showed earnings per share of 69 cents, beating the estimate of 25 cents. With 1.62M shares outstanding, the current market capitalization sits at 2.40B.

View a ticker or compare two or three

Compare

TMDX